LCMS webinars focusing on LC/MS - page 91

We will discuss the challenges associated with these analyses and present strategies that can be deployed to reduce uncertainty in LC/MS extractable studies.

Learn all about NDSRIs and their impact on drug safety and compliance.

Learn how your colleagues have upskilled their lab capabilities and technologies to elucidate the nature of unknown materials in complex drug substances, using a variety of analytical techniques.

Detecting the presence, quantity and quality of psychedelics is crucial to research development and involves various analytical tools such as HPLC with optical or MS detection and other.

Our expert speakers will share their knowledge and experience, and also discuss the latest advances in the field.

Gavin Shear (Mestrelab) will describe expert tools to the desktop user, with game changing enhancements in peak picking, spectral display, and spectral substraction using Mnova MSChrom.

How direct ionization mass spectrometry can be used for rapid screening of drugs, including the mechanism of ASAP ionization.

During the webinar, the challenges of ultra-low-level detection of PFAS will be discussed while demonstrating how the latest innovations at Waters could help you overcome them.

We will explore how USP responded to the nitrosamine impurities crisis with a proposed general chapter on nitrosamine impurities.

You will see how we developed a method that couples HILIC with Zeno trap-enabled MRMHR in order to acquire the isotopic labeling information at the intact metabolite and moiety level simultaneously.